Holen Sie sich die Stockscreener-App
6.58
1.79%
-0.12
Handel nachbörslich:
6.57
-0.010
-0.15%
Schlusskurs vom Vortag:
$6.70
Offen:
$6.67
24-Stunden-Volumen:
66,281
Relative Volume:
0.45
Marktkapitalisierung:
$328.76M
Einnahmen:
$13.56M
Nettoeinkommen (Verlust:
$-26.97M
KGV:
-11.46
EPS:
-0.5742
Netto-Cashflow:
$-24.04M
1W Leistung:
+1.39%
1M Leistung:
-13.19%
6M Leistung:
+31.08%
1J Leistung:
+70.25%
1-Tages-Spanne:
$6.54
$6.72
1-Wochen-Bereich:
$6.5126
$6.90
52-Wochen-Spanne:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Firmenname
Capsovision Inc
Sektor
Branche
Telefon
(408) 370-4790
Adresse
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.58 | 330.26M | 13.56M | -26.97M | -24.04M | -0.5742 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Roth Capital | Buy |
| 2025-07-28 | Eingeleitet | The Benchmark Company | Speculative Buy |
Capsovision Inc Aktie (CV) Neueste Nachrichten
CapsoVision Inc (CV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CV|CapsoVision Inc|Price:6.620|Chg%:+0.130 - TradingKey
CapsoVision Inc (CV) Cash Flow - TradingKey
CapsoVision Inc (CV) Balance Sheet - TradingKey
CapsoVision Inc (CV) Income Statement - TradingKey
CapsoVision Inc (CV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CapsoVision Inc (CV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CapsoVision Inc (CV) Valuation: PE, PB & Fair Value Analysis - TradingKey
CapsoVision Inc (CV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CV|CapsoVision Inc|Price:6.540|Chg%:+0.050 - TradingKey
CapsoVision Inc (CV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 4 CapsoVision Inc For: 21 July By Investing.com - Investing.com Canada
CapsoVision director Eliyahou Harari buys $410k in company stock - Investing.com
CapsoVision director Eliyahou Harari buys $410k in company stock By Investing.com - Investing.com Nigeria
CapsoVision 10% owner Eliyahou Harari reports purchase of 61,068 common shares for $410,987.64 - Bitget
U.S. Smart Pills Market to Reach US$ 619.10 Million by 2033 as - openPR.com
CapsoVision (CV) AGM 2026 Summary - Quartr
CapsoVision Inc. (CV) Surges 3.81% as Shares Test Key Resistance LevelsEMA Signal - dars.gov.et
Form 4 CapsoVision Inc For: 10 July By Investing.com - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $495,117 in stock By Investing.com - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $495,117 in stock - Investing.com
Insider Buyers Lose US$22k As CapsoVision Sheds US$75m - simplywall.st
CapsoVision 10% owner Eliyahou Harari buys $101,811 in CV stock By Investing.com - Investing.com Australia
Form 4 CapsoVision Inc For: 7 July By Investing.com - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $101,811 in CV stock - Investing.com
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors - The Manila Times
CapsoVision appoints gastroenterologist David Shields to board - Investing.com
CapsoVision adds Shields to board, refines clinical focus - TipRanks
CapsoVision appoints gastroenterologist David Shields to board By Investing.com - Investing.com Canada
Director at CapsoVision (CV) awarded 1,710 RSUs vesting in 2026 - Stock Titan
CapsoVision director Joanne Imperial sells $8,586 in common stock By Investing.com - Investing.com Australia
CapsoVision director Joanne Imperial sells $8,586 in common stock - Investing.com
Form 4 CapsoVision Inc For: 1 July By Investing.com - Investing.com Canada
Director Tsai Chen Lung adds CapsoVision (CV) shares via RSU vesting - Stock Titan
CapsoVision (CV) director converts RSUs into 2,022 common shares in equity grant vesting - Stock Titan
CapsoVision, Inc.(NasdaqCM:CV) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 3000E Value Benchmark - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 3000 Value Benchmark - marketscreener.com
CapsoVision, Inc.(NasdaqCM: CV) dropped from Russell 2000 Value Benchmark - marketscreener.com
Here's Why We're Watching CapsoVision's (NASDAQ:CV) Cash Burn Situation - Moomoo
CapsoVision, Inc. Actuals & Estimates (NASDAQ:CV) - TradingView
CapsoVision, Inc. Actuals & Estimates (DUS:H6U) - TradingView
CV Forecast — Price Target — Prediction for 2027 - TradingView
H6U Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of CapsoVision, Inc. – NASDAQ:CV - TradingView
Price to sales forward of CapsoVision, Inc. – NASDAQ:CV - TradingView
CapsoVision, Inc. (CV) Stock Live Price, Chart & News - CoinCodex
CapsoVision Inc (CV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CapsoVision Inc. (CV) Edges Higher, Testing Key Resistance LevelsPrice Action Signals - DonanımHaber
CV Q1 2026 Earnings: EPS Misses Estimates, Stock Rises 1.69%Full Year Guidance - dars.gov.et
Finanzdaten der Capsovision Inc-Aktie (CV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Capsovision Inc-Aktie (CV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HARARI ELIYAHOU ET AL | 10% Owner |
Jul 08 '26 |
Buy |
6.09 |
81,300 |
495,117 |
3,282,051 |
| HARARI ELIYAHOU ET AL | 10% Owner |
Jun 26 '26 |
Buy |
7.35 |
13,850 |
101,811 |
3,200,751 |
| Imperial Joanne Carol | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
3,709 |
| Tsai Chen Lung | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
4,929 |
| Kuo Hui Ying | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
15,263 |
| King Wen-Herng Henry | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
25,619 |
| Harari Michele | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
61,065 |
| GOUW JULIA S | Director |
Jun 30 '26 |
Option Exercise |
7.58 |
2,022 |
15,327 |
4,909 |
| Atkinson Douglas Patrick | Head of Global Sales |
May 04 '26 |
Option Exercise |
0.34 |
72,571 |
25,000 |
72,571 |
| Atkinson Douglas Patrick | Head of Global Sales |
May 05 '26 |
Option Exercise |
0.57 |
34,786 |
19,692 |
107,357 |
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):